Yan, Sherry X <br/><br/>
Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  05 2019 
 - 147-153 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2019.03.031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--mortality<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lung Neoplasms--mortality<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Radiosurgery--methods<br/>Radiotherapy Dosage<br/>Survival Analysis<br/>Treatment Outcome